Dr. Page-Wilson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
180 Fort Washington Avenue
Floor 5th, Suite 512
New York, NY 10032- Is this information wrong?
Summary
- Dr. Gabrielle Page-Wilson is an endocrinologist in New York, NY and is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Harvard Medical School and has been in practice 11 years. She specializes in complex hormonal disorders including pituitary disorders, disorders of reproduction in both men and women, menopause, neuroendocrinology and obesity. She has extensive clinical research experience and has served as a Principal Investigator for NIH funded and sponsored clinical trials. She has over 25 publications and speaks nationally on diverse endocrine topics.
Education & Training
- Brigham and Women's HospitalResidency, Internal Medicine, 2008
- Harvard Medical SchoolClass of 2005
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism
Certifications & Licensure
- FL State Medical License 2021 - 2026
- NY State Medical License 2008 - 2025
- NJ State Medical License 2022 - 2025
- PA State Medical License 2024 - 2024
- CT State Medical License 2022 - 2024
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole Start of enrollment: 2016 Sep 16
- Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's Disease Start of enrollment: 2018 Jul 16
Publications & Presentations
PubMed
- Pregnancy-specific Adaptations in Leptin and Melanocortin Neuropeptides in Early Human Gestation.Andrikopoulou M, Panigrahi SK, Jaconia GD, Gyamfi-Bannerman C, Smiley RM, Page-Wilson G> ;The Journal of clinical endocrinology and metabolism.
- Ropinirole for the Treatment of Hyperprolactinemia: A Dose-Escalation Study of Efficacy and Tolerability.Amanda Tsang, Cara Dimino, Alexander G Khandji, Gabrielle Page-Wilson, Liam J Heneghan, Sunil K Panigrahi> ;The Journal of Clinical Endocrinology and Metabolism. 2024 Jan 18
- 2 citationsThe treatment of aggressive prolactinomas with everolimus.Andrew L Lin, Eliza B Geer, Nupur Lala, Gabrielle Page-Wilson, Rajiv Magge, Robert J Young, Viviane Tabar> ;Pituitary. 2023 Aug 1
- Join now to see all
Press Mentions
- Treatment of Hyperprolactinemia with the Non-Ergoline Dopamine Agonist RopiniroleJanuary 31st, 2017
Professional Memberships
- Member
Hospital Affiliations
- NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: